Biosimilar Characterization R&D Facility Opens in Austria

News   Oct 23, 2013

 
Biosimilar Characterization R&D Facility Opens in Austria
 
 
 
 

RELATED ARTICLES

Ingestible Drug-Delivery Materials May Improve Patient Treatment Compliance

News

Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.

READ MORE

Nanoparticle Delivery of Curcumin Induces Tumor Cell Death

News

Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cells

READ MORE

3,000-Year-Old Textiles Are Earliest Evidence of Chemical Dyeing

News

Discovery provides insight into society and copper production in the Timna region at the time of David and Solomon.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE